Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

002118

CNE000001R43

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Approves Board Appointments

May 31, 2023 at 01:03 am IST

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. at its Annual General Meeting of 2022 on 29 May 2023, during which the company approved: Election and nomination of non-independent directors of Meng Xiangjin; Xu Wenqing
Sun Zuoyun. Election and nomination of independent directors; Palidan Niyazi; Li Tuo.

Latest news about Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange A Share Index	04/23/04	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Composite Index	04/23/04	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Approves Board Appointments	31/23/31	CI
Jilin Zixin Pharma CFO Resigns; Successor Named; Shares Slump 5%	11/23/11	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt	08/23/08	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Jilin Zixin Pharma Chairman Resigns	19/23/19	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Appoints Chen Fu as Non-Independent Directors	17/23/17	CI
Jilin Zixin Pharma Elects Chairman	16/23/16	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/22/29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt	29/22/29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Announces Board Changes	25/22/25	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/21/29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	29/21/29	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	23/21/23	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(XSEC:002118) dropped from S&P Global BMI Index	21/20/21	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Component A Share Index	14/20/14	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Component Index	11/20/11	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	27/20/27	CI
Jilin Hengde Investment Information Consulting Co., Ltd. agreed to acquire Jilin Zixin Dunhua Medicine & Herbs Co., Ltd. from Jilin Zixin Pharmaceutical Industrial Co.,Ltd. for CNY 1 million.	28/20/28	CI

Chart Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

Duration

Period

Chart Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

More charts

Company Profile

JILIN ZIXIN PHARMACEUTICAL INDUSTRIAL CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of traditional Chinese patent drugs and ginseng products. The Company operates its businesses through three segments. The Traditional Chinese Patent Drugs segment mainly provides traditional Chinese patent drugs for the treatment of rheumatoid immunity, ear-nose-throat (ENT), urinary system cardiovascular, hepatobiliary and digestive diseases. The Ginseng Products segment is engaged in the provision of deep processing products and rough-wrought products, including white ginseng products, red ginseng products, drinks and candied fruits. The Gene Sequencing segment is engaged in the research and development, manufacture and distribution of gene sequencing machines and supporting reagents.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+26.93%	5.55B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-33.55%	3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-3.74%	3.03B
TASLY PHARMACEUTICAL GROUP CO., LTD	-26.09%	2.59B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-10.93%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.88B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+41.84%	1.46B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-12.94%	1.43B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+47.62%	1.42B

Alternative Medicine